ANI Pharmaceuticals (ANIP)

[Just the facts maam]

I agree, Jeff, especially when prior to the merger Wells Fargo owned over 50% of ANIP through their subsidiary MVP. $18 million for additional shares would have been a no brainer. In my opinion Abbvie wanted Libigel and manufacturing capability and capacity. This merger gave them both in one future transaction.

Jeff, don't be surprised if the efficacy data from the long term safety study is sufficient to just justify getting it on the market for HSDD. Since Addyi was approved for pre-menopausal women with a much riskier profile. It was the first FDA approved drug to treat HSDD. Time for a drug to treat post menopausal women. Risk vs Reward.